ribavirin has been researched along with Focal Segmental Glomerulosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, A; Midha, V; Mittal, R; Puri, S; Sandhu, JS; Sood, A; Sood, N | 1 |
| Sperati, CJ | 1 |
| Alves Couto, C; Costa Faria, L; de Abreu Ferrari, TC; de Melo Couto, OF; de Paula Farah, K; Dias Ribeiro, D | 1 |
3 other study(ies) available for ribavirin and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Diuretics; Glomerulosclerosis, Focal Segmental; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Stabilization of hepatitis C associated collapsing focal segmental glomerulosclerosis with interferon alpha-2a and ribavirin.
Topics: Antiviral Agents; Biopsy; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2013 |
Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia | 2006 |